Roche has launched what it says is a first-of-its-kind handheld glucose management device, backed up by a digital platform that aims to simplify the work of doctors and nurses as they deliv
A prescription digital therapeutic (DTx) for leukaemia patients developed by Blue Note Therapeutics has been awarded breakthrough device status by the FDA.
US medical device company Abbott has said it plans to launch a new range of 'biowearable' health devices aimed at consumers, in a move that builds on its expertise in glucose monitoring.
The Biden administration has launched a fact-finding mission to try to find ways to deploy digital health technologies effectively in community settings, in order to boost "individual welln
In the second part of our examination of issues that will shape the course of 2022, we’ll update the ongoing impacts of the pandemic, which have, as they did in 2021, a pervasive effect on